Cite
HARVARD Citation
Papayanni, P. et al. (2021). Vaccinated and Convalescent Donor–Derived Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients. Clinical infectious diseases. pp. 2073-2082. [Online].